DK1228097T3 - Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge - Google Patents

Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge

Info

Publication number
DK1228097T3
DK1228097T3 DK00981916T DK00981916T DK1228097T3 DK 1228097 T3 DK1228097 T3 DK 1228097T3 DK 00981916 T DK00981916 T DK 00981916T DK 00981916 T DK00981916 T DK 00981916T DK 1228097 T3 DK1228097 T3 DK 1228097T3
Authority
DK
Denmark
Prior art keywords
human lactoferrin
cluster
antimicrobial activity
polypeptides
cationic
Prior art date
Application number
DK00981916T
Other languages
English (en)
Inventor
Berkel Patrick Hendrikus C Van
Peter Hendrikus Nibbering
Jan Henricus Nuijens
Original Assignee
Am Pharma Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Am Pharma Bv filed Critical Am Pharma Bv
Application granted granted Critical
Publication of DK1228097T3 publication Critical patent/DK1228097T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK00981916T 1999-11-11 2000-11-10 Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge DK1228097T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16497599P 1999-11-11 1999-11-11
EP99203775 1999-11-11

Publications (1)

Publication Number Publication Date
DK1228097T3 true DK1228097T3 (da) 2006-04-18

Family

ID=26153390

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00981916T DK1228097T3 (da) 1999-11-11 2000-11-10 Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge

Country Status (11)

Country Link
EP (1) EP1228097B1 (da)
JP (1) JP2003521483A (da)
AT (1) ATE313562T1 (da)
AU (1) AU776044B2 (da)
CA (1) CA2388910C (da)
CY (1) CY1105008T1 (da)
DE (1) DE60025026T2 (da)
DK (1) DK1228097T3 (da)
ES (1) ES2256070T3 (da)
PT (1) PT1228097E (da)
WO (1) WO2001034641A2 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001072322A2 (en) * 2000-03-27 2001-10-04 Pharming Intellectual Property B.V. High dosage parenteral administration of lactoferrin
EP1414866A2 (en) 2000-11-21 2004-05-06 The Texas A & M University System Fgf-affinity chromatography
EP1360961A1 (en) * 2002-05-07 2003-11-12 AM-Pharma B.V. Use of antimicrobial peptides for potentiating the activity of antimicrobial agents
US20070207953A1 (en) * 2003-07-16 2007-09-06 Altura Burton M Host Defense Factor X (HDFX)
WO2007055578A1 (en) * 2005-11-11 2007-05-18 Leids Universitair Medisch Centrum Cyclic antimicrobial peptides derived from lactoferrin
WO2008006125A1 (en) * 2006-07-10 2008-01-17 Österreichische Akademie der Wissenschaften Antimicrobial peptides
EP2030980A1 (en) * 2007-08-28 2009-03-04 AM-Pharma B.V. Mutants of lactoferrin
EP2050461A1 (en) 2007-10-19 2009-04-22 PharmaSurgics in Sweden AB Peptides based on the sequence of human lactoferrin and their use
EP2060586A1 (en) 2007-11-14 2009-05-20 PharmaSurgics in Sweden AB New synthetic arginine substituted peptides and their use
EP2481751A1 (en) 2011-01-26 2012-08-01 PharmaSurgics in Sweden AB Human lactoferrin derived peptides
JP6099055B2 (ja) * 2014-05-09 2017-03-22 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 変性病変の診断のためのリガンドとしてのフコイダン
CN107304424B (zh) * 2016-05-23 2019-05-10 成都福际生物技术有限公司 改造的转铁蛋白dna结合域、重组dna聚合酶及制备方法
WO2019139891A1 (en) 2018-01-09 2019-07-18 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
CA3094173A1 (en) 2018-03-20 2019-09-26 Synthetic Biologics, Inc. Intestinal alkaline phosphatase formulations
WO2019183209A1 (en) 2018-03-20 2019-09-26 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of radiation disorders
US20230190652A1 (en) * 2020-04-16 2023-06-22 Dermopartners,S.L. Composition for the treatment of covid-19 and treatment method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656591A (en) * 1992-01-23 1997-08-12 Morinaga Milk Industry Co., Ltd. Antimicrobial agents and method for treating products therewith
WO1995022258A2 (en) * 1994-02-16 1995-08-24 Pharming Bv Isolation of lactoferrin from milk
JP3506274B2 (ja) * 1994-09-01 2004-03-15 雪印乳業株式会社 新規ペプチドおよび免疫賦活剤
JPH1192375A (ja) * 1997-09-25 1999-04-06 Morinaga Milk Ind Co Ltd ニューキノロン系抗菌剤の抗菌性を増強させる抗菌剤

Also Published As

Publication number Publication date
WO2001034641A2 (en) 2001-05-17
AU776044B2 (en) 2004-08-26
DE60025026T2 (de) 2006-08-03
AU1901501A (en) 2001-06-06
CY1105008T1 (el) 2009-11-04
PT1228097E (pt) 2006-05-31
CA2388910C (en) 2008-10-07
EP1228097B1 (en) 2005-12-21
ES2256070T3 (es) 2006-07-16
DE60025026D1 (de) 2006-01-26
EP1228097A2 (en) 2002-08-07
WO2001034641A8 (en) 2002-05-10
CA2388910A1 (en) 2001-05-17
WO2001034641A3 (en) 2002-02-14
JP2003521483A (ja) 2003-07-15
ATE313562T1 (de) 2006-01-15

Similar Documents

Publication Publication Date Title
CY1105008T1 (el) Αντιμικροβιακη ενεργοτητα του πρωτου κατιονικου συγκροτηματος της ανθρωπινης λακτοφερρινης
HRP20020880B1 (en) New pharmaceutical composition
LTC1131065I2 (lt) Dialkilfumaratai, skirti autoimuninėms ligoms gydyti
BR9811956B1 (pt) naftiridinonas e composição farmacêutica compreendendo as mesmas.
ATE300533T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate als urotensin ii rezeptor-antagonisten
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
DE60033649D1 (de) Verbindungen und therapeutische methoden
DE69938935D1 (de) Zyklische conotoxin-peptide
DE69819145D1 (de) Bioabbaubare mikropartikeln mit verzögerter wirkstofffreisetzung
TR200100637T2 (tr) Yeni doğal ürün türevleri
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
ATE386525T1 (de) 3-substituierte 6,7- dihydroxytetrahydroisochinolin-derivate zur verwendung als antibkaterielle mittel
ATE395064T1 (de) Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
EA200000909A1 (ru) ФОРМА VI 5,6-ДИХЛОР-2-(ИЗОПРОПИЛАМИНО)-1-(b-L-РИБОФУРАНОЗИЛ)-1H-БЕНЗИМИДАЗОЛА
MXPA02012015A (es) Ligandos de receptores para integrinas.
DK1189615T3 (da) Endoparasiticid synergistisk kombination indeholdende cykliske depsipeptider og piperaziner
DE60003074D1 (de) Fusidinsäure-derivate
ES2192034T3 (es) Feniluracilos substituidos con efecto herbicida.
NO20020914D0 (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
ATE287716T1 (de) Metallsalze als antimykotika
AR026890A1 (es) Composiciones de tenocitos, preparaciones y utilizaciones
RU2003124254A (ru) Косметическое средство для ухода за кожей лица и шеи
DE50212538D1 (de) Substituierte 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzoäcüfluoren-6-carbonsäurederivate als nmda-antagonisten
ITFI20030238A1 (it) Peptidi ciclici antagonisti dell'urotensina-ii
UY24489A1 (es) Compuestos de dimetil-(3-aril-but-3-enil)-amina, procedimiento para su preparación y aplicación de estos compuestos en medicamentos.